Non-invasive topical drug delivery to spinal cord with carboxyl-modified trifunctional copolymer of ethylene oxide and propylene oxide by Kamalov M. et al.
Colloids and Surfaces B: Biointerfaces 140 (2016) 196–203
Contents lists available at ScienceDirect
Colloids  and  Surfaces  B:  Biointerfaces
jo ur nal ho me p ag e: www.elsev ier .com/ locate /co lsur fb
Non-invasive  topical  drug  delivery  to  spinal  cord  with
carboxyl-modiﬁed  trifunctional  copolymer  of  ethylene  oxide  and
propylene  oxide
Marat  I.  Kamalova, Igor  A.  Lavrova,∗, Abdulla  A.  Yergeshova, Zulﬁra  Y.  Siraevaa,
Maxim  E.  Baltina,  Albert  A.  Rizvanova,  Svetlana  V.  Kuznetcovaa, Natalia  V.  Petrovaa,
Irina  N.  Savinab,  Timur  I.  Abdullina,∗
a Kazan (Volga Region) Federal University, 18 Kremlyovskaya St., 420008 Kazan, Russia
b School of Pharmacy and Biomolecular Sciences, University of Brighton, Huxley Building, Lewes Road, Brighton BN2 4GJ, UK
a  r  t  i  c  l e  i  n  f  o
Article history:
Received 25 August 2015
Received in revised form
20 November 2015
Accepted 18 December 2015
Available online 24 December 2015
Keywords:
Amphiphilic polymers
Trifunctional copolymers of ethylene oxide
and propylene oxide
Oxidative modiﬁcation
Micelles
Drug delivery
Neural cells
Spinal cord
Traumatic injury
a  b  s  t  r  a  c  t
In this  study  the  effect  of  oxidative  modiﬁcation  on  micellar  and  drug  delivery  properties  of copolymers  of
ethylene oxide  (EO)  and  propylene  oxide  (PO)  was  investigated.  Carboxylated  trifunctional  copolymers
were  synthesized  in the  reaction  with  chromium(VI)  oxide.  We  found  that  carboxylation  signiﬁcantly
improved  the uniformity  and  stability  of  polymeric  micelles  by  inhibiting  the  microphase  transition.  The
cytotoxicity  of copolymers  was  studied  in relation  to their  aggregative  state  on  two  cell types  (cancer
line  vs. primary  ﬁbroblasts).  The  accumulation  of  rhodamine  123  in neuroblastoma  SH-SY5Y  cells  was
dramatically  increased  in  the  presence  of the  oxidized  block  copolymer  with  the  number  of  PO  and
EO  units  of 83.5  and 24.2,  respectively.  The  copolymer  was  also  tested  as  an  enhancer  for  topical  drug
delivery  to the  spinal  cord  when  applied  subdurally.  The  oxidized  copolymer  facilitated  the  penetration
of  rhodamine  123  across  spinal  cord  tissues  and  increased  its  intraspinal  accumulation.  These  results
show  the potential  of using  oxidized  EO/PO  based  polymers  for non-invasive  delivery  of protective  drugs
after  spinal  cord  injury.
© 2015  Elsevier  B.V.  All  rights  reserved.
1. Introduction
Although a number of synthetic and biological substances were
suggested as neuroprotectors, there is still a lack of available ther-
apy for neurotrauma and particularly for spinal cord (SC) injury [1].
The only clinically accepted substance to cure the acute spinal cord
injury is high-dose intravenous infusion of methylprednisolone,
which is nevertheless controversial and related with serious side
effects [2].
A line of potential agents with the neuroprotective activity has
been studied over the last years, such as antioxidants [3], antago-
nists for glutamate excitotoxicity [4], and others. Recently polymers
and colloids attract interest of researchers as promising neuropro-
tective agents and also a system for drug delivery.
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Borgens and co-workers demonstrated that the administration
of low molecular weight PEG to guinea pigs after severe spinal
cord injury results in a signiﬁcant recovery of nerve conduction
and inhibition of consequences of secondary trauma [5,6]. Several
mechanisms for PEG-assisted neuroprotection have been proposed,
including direct sealing of the plasma membrane of damaged nerve
cells, inhibition of calcium inﬂux and oxidative stress, mitochon-
dria protection and apoptosis inhibition [5,6]. The polymer-based
therapy has been extended to PEG-related amphiphilic polymers,
e.g. the block copolymer of ethylene oxide (EO) and propylene
oxide (PO) Pluronic F68 (Poloxamer 188) [7] and PEG–polylactic
acid (PLA) copolymer [8], which exhibited neuroprotective effect
in SC injury at lower dose than that for PEG.
Other approaches to treating SC injury have been focused on the
local polymer-assisted transfer of bioactive substances to the dam-
aged spinal cord. Most studies in this ﬁeld have reported gel and
nanoparticle-based formulations with encapsulated drugs, which
are intrathecally injected in the SC. Gupta et al. proposed fast-
gelling hyaluronan/methylcellulose composite which exhibited
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